Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
申请人:BEECHAM GROUP PLC
公开号:EP0089154A2
公开(公告)日:1983-09-21
compound of formula (I):
wherein;
R' is hydrogen, halogen or trifluoromethyl,
R2 is hydrogen or halogen,
R3 is hydrogen or methyl,
R4 is hydrogen or methyl,
n is 1 or 2
R5 is optionally substituted benzyl or C1-12 straight or branched alkyl optionally substituted by carboxy, C1-6 alkoxycarbonyl, benzyloxycarbonyl, aminocarbonyl, mono- or di-(C1-6)alkylamino-carbonyl, hydroxy, C1-6 alkoxy, benzyloxy, phenoxy, amino, mono- or di-(C1-6)alkylamino, C1-6 alkylthio, benzylthio or pheny-Ithio provided that, when R6 is alkyl substituted by hydroxy, alkoxy, alkylthio, phenylthio, benzylthio, amino, alkylamino or benzyloxy, such substituents are separated from the sulphur atom by at least two carbon atoms, and
Y is methylene or a bond; is useful in treating obesity and hyperglycaemia.
式(I)化合物:
其中
R' 是氢、卤素或三氟甲基、
R2 是氢或卤素
R3 是氢或甲基
R4 是氢或甲基、
n 是 1 或 2
R5 是任选被取代的苄基或 C1-12 直链或支链烷基,任选被羧基、C1-6 烷氧基羰基、苄氧基羰基、氨基羰基、单-或二-(C1-6)烷基氨基羰基、羟基、C1-6 烷氧基、苄氧基、苯氧基、氨基、单-或二-(C1-6)烷基氨基取代、C1-6烷硫基、苄硫基或苯硫基,但当 R6 是被羟基、烷氧基、烷硫基、苯硫基、苄硫基、氨基、烷基氨基或苄氧基取代的烷基时,这些取代基与硫原子之间至少间隔两个碳原子,且
Y 是亚甲基或键;可用于治疗肥胖症和高血糖症。